PUNURU REDDY: Open Payments
NPI 1760541197 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 24 payments from 12 companies in 2025. Trend: 2023 $886 · 2024 $468 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $85 |
| GlaxoSmithKline, LLC. | 4 | $61 |
| Vanda Pharmaceuticals Inc. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| PFIZER INC. | 2 | $45 |
| Lilly USA, LLC | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Abbott Laboratories | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
Products named: TRELEGY ELLIPTA, FANAPT, VERQUVO, ELIQUIS, Ozempic, Rybelsus, AIRSUPRA, KISUNLA.
Industry payments across AL — which companies pay providers there.
